APA 6th Edition Tešović, G. (2018). Azitromicin u djece. Medicus, 27 (2 Sumamed), 135-141. Retrieved from https://hrcak.srce.hr/214606
MLA 8th Edition Tešović, Goran. "Azitromicin u djece." Medicus, vol. 27, no. 2 Sumamed, 2018, pp. 135-141. https://hrcak.srce.hr/214606. Accessed 30 Mar. 2020.
Chicago 17th Edition Tešović, Goran. "Azitromicin u djece." Medicus 27, no. 2 Sumamed (2018): 135-141. https://hrcak.srce.hr/214606
Harvard Tešović, G. (2018). 'Azitromicin u djece', Medicus, 27(2 Sumamed), pp. 135-141. Available at: https://hrcak.srce.hr/214606 (Accessed 30 March 2020)
Vancouver Tešović G. Azitromicin u djece. Medicus [Internet]. 2018 [cited 2020 March 30];27(2 Sumamed):135-141. Available from: https://hrcak.srce.hr/214606
IEEE G. Tešović, "Azitromicin u djece", Medicus, vol.27, no. 2 Sumamed, pp. 135-141, 2018. [Online]. Available: https://hrcak.srce.hr/214606. [Accessed: 30 March 2020]
Abstracts Despite the increasing macrolide resistance among the most common respiratory pathogens, especially in countries with a long-term use of macrolides, azithromycin plays an important role in the treatment of frequent infections in children. Respiratory infections, primarily community-acquired pneumonia, among children above the age of 5 in particular, as well as therapeutic combination for the treatment of pneumonia in younger children with suspected mixed infection or severe/complicated course of clinical disease, remain an important indication area for azithromycin. Moreover, evidence of the role of atypical bacteria (Mycoplasma pneumoniae and Chlamydia pneumoniae) in the aetiology of acute tonsillopharyngitis and asthma, as well as the continuous presence of whooping cough in population, point out clear indications for the use of macrolides/azalides in paediatric medicine. The treatment of streptococcal tonsillopharyngitis in Croatia, where macrolide resistance in Streptococcus pyogenes is about 7%, also remains an indication for the administration of macrolides/azalides, particularly in the case of beta-lactame antibiotic allergy and in the cases where treatment can be initiated following the receipt of bacteriological findings for throat swab. Azithromycin should undoubtedly be used in the treatment of non-respiratory infections such as cat-scratch disease (infections caused by Bartonella henselae), antimicrobial therapy of bacterial diarrhoea and traveller's diarrhoea, solitary erythema migrans (Lyme borreliosis), some neonatal infections (chlamydial conjunctivitis and pneumonia), as well as some other infections (skin and soft tissue infections such as impetigo, erysipelas, cellulitis, folliculitis and paronychia, and cryptosporidiosis, meningococcal prophylaxis, cystic fibrosis exacerbations).